Study of Istradefylline (KW-6002) for the Treatment of Restless Legs Syndrome
NCT00199446
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
160
Enrollment
INDUSTRY
Sponsor class
Conditions
Sleep Disorder
Restless Legs Syndrome
Interventions
DRUG:
Istradefylline (KW-6002)
Sponsor
Kyowa Kirin, Inc.
Collaborators
[object Object]